期刊文献+

老年食管癌放化疗结合治疗的效果与安全性 被引量:4

Efficacy and Safety of Combined Radiotherapy and Chemotherapy in Elderly Patients With Esophageal Cancer
下载PDF
导出
摘要 目的讨论老年食管癌放化疗结合治疗的效果与安全性。方法选择本院2017年3月-2019年3月收治的114例老年食管癌患者作为本次研究的观察对象,并随机将其分为对照组(实施单纯性放疗治疗方案)与研究组(实施放化疗结合的治疗方案),评判标准:治疗效果及治疗安全性。结果研究组患者治疗合计有效率73.68%高于对照组的54.39%,P<0.05;两组患者治疗后不良反应发生率差异无统计学意义,P>0.05。结论与单纯性放疗治疗相比,放化疗联合治疗方案的实施可有效提高老年食管癌病症的治疗效果,且其治疗安全性与放疗治疗相比差异无统计学意义。 Objective To discuss efficacy and safety of combined radiotherapy and chemotherapy for elderly esophageal cancer.Methods114 elderly patients with esophageal cancer admitted to our hospital from March 2017 to March 2019 were selected as the subjects.They were randomly divided into control group(simple radiotherapy)and research group(radiotherapy combined with chemotherapy).The evaluation criteria were therapeutic effect and safety.Results The total effective rate of the study group was 73.68%,which was significantly higher than control group54.39%,P<0.05.There was no difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Compared with radiotherapy alone,the combination of chemoradiotherapy and radiotherapy can effectively improve the therapeutic effect of esophageal cancer in the elderly,and its therapeutic safety is no different from that of radiotherapy.
作者 陈峰 CHEN Feng(Department of Oncology,Xintai People's Hospital,Xintai Shandong 271200,China)
出处 《中国卫生标准管理》 2019年第14期48-50,共3页 China Health Standard Management
关键词 老年患者 食管癌 放疗 化疗 治疗效果 治疗安全性 elderly patients esophageal cancer radiotherapy chemotherapy therapeutic effect therapeutic safety
  • 相关文献

参考文献12

二级参考文献65

  • 1王晓翔.放疗联合顺铂+氟尿嘧啶方案同步化疗治疗局部晚期食管癌的实效性探究[J].中国生化药物杂志,2014,34(2):86-88. 被引量:13
  • 2张宜勤,陆进成,翟振宇,魏青.三维适形放疗食管癌临床研究的初步结果[J].中华放射肿瘤学杂志,2005,14(1):31-34. 被引量:115
  • 3朱孝贞,尹淑玲,陈秋立,郭宝仲,高淑珍,万钧.2722例食管癌放射治疗分析[J]中国放射肿瘤学,1988(04).
  • 4孙明瑜,左剑,段继峰,韩军,范士明,张炜,朱丽芳,姚明辉.苦参总黄酮体内外抗肿瘤作用实验研究[J].中西医结合学报,2008,6(1):51-59. 被引量:13
  • 5Suntharalingam M, Moughan J, Coia LR, et al. The national practice for patients receiving radiation therapy for carcinoma of the esophagus:results of the 1996-1999 patterns of care study[ J ]. Int J Radiat Oncol Biol Phys, 2003, 56 (4) : 981-987.
  • 6Wong RK, Mahhaner RA, Zuraw L, et al. Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline[ J ]. Int J Radiat Oncol Biol Phys, 2003, 55(4) :930-942.
  • 7Kato H, Fukchi M, Manda R, et al. Efficacy and toxicity of nedaplatin an d 5-FU with radiation treatment for advanced esophageal carcinomas [ J ]. Anticancer Res, 2003, 23 (4) :3493-3498.
  • 8Takeuchi S, Ohtsu A, Doi T, et al. A retrospective study ofdefinitive chemoradiotherapy for elderly patients with esophageal cancer. AmJ Clin Oncol, 2007, 30(6): 607-611.
  • 9Ilson DH, Wadleigh RG, Leichman LP, et al. Paclitaxel given by aweekly 1-h infusion in advanced esophageal cancer.Ann oncol,2007,18(5):898-902.
  • 10Inaba H, Tsuda T, Miyazaki A, et al. Clinical study of thecombination of small amount of nedaplatin( CDGP)/5-Fu with radiationfor the treatment of esophageal cancer. Nippon Shokakibyo Gakkai Zasshi,2002, 99(10): 1191-1196.

共引文献81

同被引文献28

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部